Citation Impact
Citing Papers
Modulation of immune cell reactivity with cis -binding Siglec agonists
2021 StandoutNobel
Sex Differences in the Gut Microbiome Drive Hormone-Dependent Regulation of Autoimmunity
2013 StandoutScience
HIF Hydroxylase Pathways in Cardiovascular Physiology and Medicine
2015 StandoutNobel
From oxygen to erythropoietin: Relevance of hypoxia for retinal development, health and disease
2011
Hypoxia-Inducible Factors in Physiology and Medicine
2012 StandoutNobel
Pericytes are required for blood–brain barrier integrity during embryogenesis
2010 StandoutNature
Matrix metalloproteinases and the regulation of tissue remodelling
2007 Standout
The Retinal Pigment Epithelium in Visual Function
2005 Standout
Diabetic retinopathy
2010 Standout
Long-term Treatment with Suberythropoietic Epo is Vaso- and Neuroprotective in Experimental Diabetic Retinopathy
2011
Efficacy of Intravitreal Bevacizumab for Stage 3+ Retinopathy of Prematurity
2011 Standout
Vascular endothelial growth factor-A: A multifunctional molecular player in diabetic retinopathy
2009
Role of platelet-derived growth factors in physiology and medicine
2008 Standout
Pigment epithelium-derived factor (PEDF) and vascular endothelial growth factor (VEGF) in aged human choroid and eyes with age-related macular degeneration
2005
Clonal Heterogeneity and Tumor Evolution: Past, Present, and the Future
2017 Standout
HIF-1 mediates metabolic responses to intratumoral hypoxia and oncogenic mutations
2013 StandoutNobel
Hypoxia and Inflammation
2011 Standout
Retinopathy of prematurity
2013 Standout
Influence of tumour micro-environment heterogeneity on therapeutic response
2013 StandoutNature
The Science of Stroke: Mechanisms in Search of Treatments
2010 Standout
A Phase 1 Study of Intravitreous E10030 in Combination with Ranibizumab in Neovascular Age-Related Macular Degeneration
2015
The HIF-1 antagonist acriflavine: visualization in retina and suppression of ocular neovascularization
2016 StandoutNobel
Hypoxia-Inducible Factor (HIF)/Vascular Endothelial Growth Factor (VEGF) Signaling in the Retina
2014
Sustained delivery of a HIF-1 antagonist for ocular neovascularization
2013 StandoutNobel
Mechanisms and Management of Retinopathy of Prematurity
2012
The NOX Family of ROS-Generating NADPH Oxidases: Physiology and Pathophysiology
2007 Standout
Age-related macular degeneration
2012 Standout
Ten years of anti-vascular endothelial growth factor therapy
2016
Hypoxia and the extracellular matrix: drivers of tumour metastasis
2014 StandoutNobel
Diabetic Retinopathy
2012 Standout
Differential Sensitivity of Hypoxia Inducible Factor Hydroxylation Sites to Hypoxia and Hydroxylase Inhibitors
2011 StandoutNobel
PDGF-C Mediates the Angiogenic and Tumorigenic Properties of Fibroblasts Associated with Tumors Refractory to Anti-VEGF Treatment
2009
Development and pathology of the hyaloid, choroidal and retinal vasculature
2004
Integrins as “functional hubs” in the regulation of pathological angiogenesis
2009
Oxygen sensing and hypoxia signalling pathways in animals: the implications of physiology for cancer
2013 StandoutNobel
Neurons Limit Angiogenesis by Titrating VEGF in Retina
2014
Vascular endothelial growth factor in eye disease
2008 Standout
Aptamers as targeted therapeutics: current potential and challenges
2016 Standout
Dual Antagonism of PDGF and VEGF in Neovascular Age-Related Macular Degeneration
2016
Mechanisms of Age-Related Macular Degeneration
2012
Photodynamic therapy with verteporfin in age‐related macular degeneration: a systematic review of efficacy, safety, treatment modifications and pharmacoeconomic properties
2008
Intravitreal bevacizumab in combination with laser therapy for the treatment of severe retinopathy of prematurity (ROP) associated with vitreous or retinal hemorrhage
2010
Impact of the non‐cellular tumor microenvironment on metastasis: Potential therapeutic and imaging opportunities
2007
Age-related macular degeneration
2018 Standout
Expression of VEGF and PEDF in Choroidal Neovascular Membranes Following Verteporfin Photodynamic Therapy
2006
Src Family Kinases Promote Vessel Stability by Antagonizing the Rho/ROCK Pathway
2007
Emerging therapeutic approaches in the management of retinal angiogenesis and edema
2010
Topical administration of a multi‐targeted kinase inhibitor suppresses choroidal neovascularization and retinal edema
2008
Hypoxia-inducible factor-1-dependent mechanisms of vascularization and vascular remodelling
2010 StandoutNobel
Müller cells in the healthy and diseased retina
2006 Standout
Alternative Activation of Macrophages: Mechanism and Functions
2010 Standout
Pigment epithelium-derived factor downregulates vascular endothelial growth factor (VEGF) expression and inhibits VEGF–VEGF receptor 2 binding in diabetic retinopathy
2006
The role of vascular endothelial growth factor and other endogenous interplayers in age-related macular degeneration
2008
Mechanisms for Insulin Resistance: Common Threads and Missing Links
2012 Standout
Pericytes and ocular diseases
2007
Targeting Platelet-Derived Growth Factor Receptor β+ Scaffold Formation Inhibits Choroidal Neovascularization
2016
Treatment of proliferative diabetic retinopathy with anti-VEGF agents
2011
Müller cell‐derived VEGF is a significant contributor to retinal neovascularization
2009
Vascular endothelial growth factor: a neurovascular target in neurological diseases
2016
Adenovirus-mediated HIF-1α gene transfer promotes repair of mouse airway allograft microvasculature and attenuates chronic rejection
2011 StandoutNobel
Endogenous VEGF Is Required for Visual Function: Evidence for a Survival Role on Müller Cells and Photoreceptors
2008
Histological findings of a choroidal neovascular membrane removed at the time of macular translocation in a patient previously treated with intravitreal bevacizumab treatment (Avastin)
2006
Idiopathic pulmonary fibrosis
2011 Standout
Vascular Endothelial Growth Factor A in Intraocular Vascular Disease
2012
Oxygen Sensing, Homeostasis, and Disease
2011 StandoutNobel
Vascular endothelial growth factors and angiogenesis in eye disease
2003
Carotid body hyperplasia and enhanced ventilatory responses to hypoxia in mice with heterozygous deficiency of PHD2
2013 StandoutNobel
Molecular mechanisms and clinical applications of angiogenesis
2011 StandoutNature
VEGF in Signaling and Disease: Beyond Discovery and Development
2019 Standout
Intravitreal Triamcinolone Acetonide Injection for Treatment of Refractory Diabetic Macular Edema
2009
Inhibition of oxygen sensors as a therapeutic strategy for ischaemic and inflammatory disease
2009
Hypoxia-inducible factors: mediators of cancer progression and targets for cancer therapy
2012 StandoutNobel
IL-13 signaling through the IL-13α2 receptor is involved in induction of TGF-β1 production and fibrosis
2005
Neurovascular signalling defects in neurodegeneration
2008
Microvascular lesions of diabetic retinopathy: clues towards understanding pathogenesis?
2009
Pigment Epithelium–derived Factor in Idiopathic Pulmonary Fibrosis
2004
HIF and the Lung
2011 StandoutNobel
Targeting key angiogenic pathways with a bispecific Cross MA b optimized for neovascular eye diseases
2016
Digoxin inhibits development of hypoxic pulmonary hypertension in mice
2012 StandoutNobel
MMP‐2 and MMP‐9 synergize in promoting choroidal neovascularization
2003
Angiopoietin-like 4 is a potent angiogenic factor and a novel therapeutic target for patients with proliferative diabetic retinopathy
2015 StandoutNobel
Digoxin inhibits retinal ischemia‐induced HIF‐1α expression and ocular neovascularization
2010 StandoutNobel
Combined Proteomic and Metabolomic Profiling of Serum Reveals Association of the Complement System with Obesity and Identifies Novel Markers of Body Fat Mass Changes
2011
VEGF Secreted by Hypoxic Müller Cells Induces MMP-2 Expression and Activity in Endothelial Cells to Promote Retinal Neovascularization in Proliferative Diabetic Retinopathy
2013 StandoutNobel
Intravitreal Bevacizumab for Choroidal Neovascularization Caused by AMD (IBeNA Study): Results of a Phase 1 Dose-Escalation Study
2006
Adipocyte Pseudohypoxia Suppresses Lipolysis and Facilitates Benign Adipose Tissue Expansion
2014 StandoutNobel
Müller Cell-Derived VEGF Is Essential for Diabetes-Induced Retinal Inflammation and Vascular Leakage
2010
Inositol Polyphosphate Multikinase Inhibits Angiogenesis via Inositol Pentakisphosphate-Induced HIF-1α Degradation
2017 StandoutNobel
BODIPY dyes in photodynamic therapy
2012 Standout
Pigment Epithelium–Derived Factor Regulates Lipid Metabolism via Adipose Triglyceride Lipase
2011
Reactive Oxygen Species (ROS)-Based Nanomedicine
2019 Standout
Hypoxic retinal Müller cells promote vascular permeability by HIF-1–dependent up-regulation of angiopoietin-like 4
2013 StandoutNobel
Comparative Analysis of Mutant Tyrosine Kinase Chemical Rescue
2009 StandoutNobel
Effect of chemical stabilizers of hypoxia-inducible factors on early lung development
2007
Antagonism of PDGF-BB suppresses subretinal neovascularization and enhances the effects of blocking VEGF-A
2013
Hypoxia-inducible factor 1 transcriptional activity in endothelial cells is required for acute phase cardioprotection induced by ischemic preconditioning
2012 StandoutNobel
Works of Nobuo Jo being referenced
Expression of pigment epithelium-derived factor in normal adult rat eye and experimental choroidal neovascularization.
2002
Relationship between pigment epithelium-derived factor (PEDF) and renal function in patients with diabetic retinopathy.
2008
Effective transfection of a cis element “decoy” of the nuclear factor-?B binding site into the experimental choroidal neovascularization
2002
Levels of vascular endothelial growth factor and pigment epithelium-derived factor in eyes before and after intravitreal injection of bevacizumab
2009
Upregulation of pigment epithelium-derived factor after laser photocoagulation
2001
Pars Plana Vitrectomy with Removal of Posterior Hyaloid Face in Treatment of Refractory Diabetic Macular Edema Resistant to Triamcinolone Acetonide
2006
Pigment epithelium derived factor as a neuroprotective agent against ischemic retinal injury
2001
Inhibition of Platelet-Derived Growth Factor B Signaling Enhances the Efficacy of Anti-Vascular Endothelial Growth Factor Therapy in Multiple Models of Ocular Neovascularization
2006
Vascular Endothelial Growth Factor-A Is a Survival Factor for Retinal Neurons and a Critical Neuroprotectant during the Adaptive Response to Ischemic Injury
2007
Plasma Concentration of Pigment Epithelium-Derived Factor in Patients with Diabetic Retinopathy
2007
Inhibitory effect of an antibody to cryptic collagen type IV epitopes on choroidal neovascularization.
2006